Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guise, T. A.
Right arrow Articles by Chirgwin, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guise, T. A.
Right arrow Articles by Chirgwin, J. M.
Clinical Cancer Research Vol. 12, 6213s-6216s, October 15, 2006
© 2006 American Association for Cancer Research


Advances in Treating Metastatic Bone Cancer

Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases

Theresa A. Guise1, Khalid S. Mohammad1, Gregory Clines1, Elizabeth G. Stebbins2, Darren H. Wong2, Linda S. Higgins2, Robert Vessella3, Eva Corey2, Susan Padalecki1, Larry Suva4 and John M. Chirgwin1

Authors' Affiliations: 1 University of Virginia, Charlottesville, Virginia; 2 Scios, Inc., Fremont, California; 3 University of Washington, Seattle, Washington; and 4 University of Arkansas for Medical Sciences, Little Rock, Arkansas

Requests for reprints: Theresa A. Guise, Division of Endocrinology, Department of Medicine, University of Virginia, Aurbach Medical Research Building, P. O. Box 801419, Charlottesville, VA 22903. Phone: 434-243-9284; E-mail: tag4n{at}virginia.edu.

Certain solid tumors metastasize to bone and cause osteolysis and abnormal new bone formation. The respective phenotypes of dysregulated bone destruction and bone formation represent two ends of a spectrum, and most patients will have evidence of both. The mechanisms responsible for tumor growth in bone are complex and involve tumor stimulation of the osteoclast and the osteoblast as well as the response of the bone microenvironment. Furthermore, factors that increase bone resorption, independent of tumor, such as sex steroid deficiency, may contribute to this vicious cycle of tumor growth in bone. This article discusses mechanisms and therapeutic implications of osteolytic and osteoblastic bone metastases.




This article has been cited by other articles:


Home page
IBMS BoneKEyHome page
J. J. Wysolmerski
Conversations Between Breast and Bone: Physiological Bone Loss During Lactation as Evolutionary Template for Osteolysis in Breast Cancer and Pathological Bone Loss After Menopause
IBMS BoneKEy, August 1, 2007; 4(8): 209 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.